Virus-induced immunopathology
- PMID: 8895836
- PMCID: PMC7130923
- DOI: 10.1016/s0065-3527(08)60739-3
Virus-induced immunopathology
Abstract
Several viruses cause damage to the tissue by immunopathological mechanisms. This chapter presents the principal examples of immunopathogenesis caused by the viruses, accompanied by speculations about its management. The most common mechanism of lesion development in virus induced immunopathology involves T cells. Usually, it seems that when CD8+ T cells act as the controlling cell type, lesions are acute and the outcome is decided quickly. The classic example is provided by LCM in mice. The newest candidate may turn out to be SNV infection in humans. Lesions orchestrated primarily by CD4+ T cells can be either acute or long-lasting. Curiously, in the LCMV example, if CD8+ T cells are removed from the scene, immunopathological responses may still occur and these involve CD4+ T cells. Such responses are far more chronic and of lower grade than those mediated by CD8+ T lymphocytes. One possible sequel to chronic inflammatory responses to viruses is that autoreactive inflammatory reactions are initiated and an autoimmune disease occurs. The adage that an ounce of prevention is worth a pound of cure is certainly true in the field of viral pathogenesis. Preventing viral infection or manipulating immune processes during the initial phases of infection is far more successful than attempting to counteract pathological events once underway.
Similar articles
-
Immunopathology or organ-specific autoimmunity as a consequence of virus infection.Immunol Rev. 1996 Aug;152:21-45. doi: 10.1111/j.1600-065x.1996.tb00909.x. Immunol Rev. 1996. PMID: 8930666 Review. No abstract available.
-
Exploiting 4-1BB costimulation for enhancing antiviral vaccination.Viral Immunol. 2006 Winter;19(4):593-601. doi: 10.1089/vim.2006.19.593. Viral Immunol. 2006. PMID: 17201654 Review.
-
T cell responses in the central nervous system.Nat Rev Immunol. 2017 Mar;17(3):179-194. doi: 10.1038/nri.2016.144. Epub 2017 Jan 31. Nat Rev Immunol. 2017. PMID: 28138136 Review.
-
Heterologous immunity: immunopathology, autoimmunity and protection during viral infections.Autoimmunity. 2011 Jun;44(4):328-47. doi: 10.3109/08916934.2011.523277. Epub 2011 Jan 20. Autoimmunity. 2011. PMID: 21250837 Free PMC article. Review.
-
Host-pathogen interactions.Curr Opin Immunol. 2004 Aug;16(4):439-42. doi: 10.1016/j.coi.2004.05.020. Curr Opin Immunol. 2004. PMID: 15245736 Review. No abstract available.
Cited by
-
The CD8+ T Cell Noncytotoxic Antiviral Responses.Microbiol Mol Biol Rev. 2021 May 12;85(2):e00155-20. doi: 10.1128/MMBR.00155-20. Print 2021 May 19. Microbiol Mol Biol Rev. 2021. PMID: 33980586 Free PMC article. Review.
-
Acute Generalized Exanthematous Pustulosis Following the Administration of Cephalexin: A Case Report and Review of the Literature.Cureus. 2025 Feb 18;17(2):e79205. doi: 10.7759/cureus.79205. eCollection 2025 Feb. Cureus. 2025. PMID: 40125151 Free PMC article.
-
Common Inflammatory Mechanisms in COVID-19 and Parkinson's Diseases: The Role of Microbiome, Pharmabiotics and Postbiotics in Their Prevention.J Inflamm Res. 2021 Nov 30;14:6349-6381. doi: 10.2147/JIR.S333887. eCollection 2021. J Inflamm Res. 2021. PMID: 34876830 Free PMC article. Review.
-
Controlling viral inflammatory lesions by rebalancing immune response patterns.Front Immunol. 2023 Aug 21;14:1257192. doi: 10.3389/fimmu.2023.1257192. eCollection 2023. Front Immunol. 2023. PMID: 37671156 Free PMC article. Review.
-
The role of neutralizing antibody and T-helper subtypes in protection and pathogenesis of vaccinated mice following ocular HSV-1 challenge.Immunology. 1998 Nov;95(3):352-9. doi: 10.1046/j.1365-2567.1998.00602.x. Immunology. 1998. PMID: 9824497 Free PMC article.
References
-
- Alwan W.H., Record F.M., Openshaw P.J. J. Immunol. 1993;150:5211–5218. - PubMed
-
- Anderson L.J., Heilman C.A. J. Infect. Dis. 1995;171:1–7. - PubMed
-
- Ando K., Guidotti L.G., Wirth S., Ishikawa T., Missale G., Moriyama T., Schreiber R.D., Schlicht H.J., Huang S., Chisari F.V. J. Immunol. 1994;152:3245–3253. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials